Literature DB >> 14752494

Demonstration of coronary artery flow using transthoracic Doppler echocardiography.

Ho-Joong Youn1, Elyse Foster.   

Abstract

Transthoracic Doppler echocardiography is emerging as a promising method for evaluating coronary artery disease. After a period of training, detection and measurement of distal left anterior descending coronary artery flow with transthoracic Doppler echocardiography is feasible in more than 90% of the patients. Using transthoracic Doppler echocardiography with a high-frequency transducer and special setting of low Nyquist limits, pathologic coronary flow dynamics can be demonstrated. Measurement of coronary flow reserve may impact diagnosis or clinical treatment in those: (1) with anginal chest pain and angiographically normal coronary arteries; (2) with intermediate-grade coronary obstruction where the physiologic significance is in doubt; and (3) who have had an attempt at revascularization and the effectiveness of the therapy is uncertain.

Entities:  

Mesh:

Year:  2004        PMID: 14752494     DOI: 10.1016/j.echo.2003.08.017

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  10 in total

1.  Flat panel computed tomography for non-invasive flow measurement: initial results in in-vitro studies.

Authors:  Andreas H Mahnken; Michael Grasruck; Bernhard Schmidt; Rolf W Günther; Joachim E Wildberger
Journal:  Eur Radiol       Date:  2007-12-04       Impact factor: 5.315

2.  Light cigarette smoking impairs coronary microvascular functions as severely as smoking regular cigarettes.

Authors:  Hakan Gullu; Mustafa Caliskan; Ozgur Ciftci; Dogan Erdogan; Semra Topcu; Erkan Yildirim; Aylin Yildirir; Haldun Muderrisoglu
Journal:  Heart       Date:  2007-05-13       Impact factor: 5.994

3.  Increased soluble vascular adhesion molecule-1 concentration is associated with impaired coronary flow reserve in cardiac syndrome X.

Authors:  Byung Ju Shim; Dong Hyeon Lee; Ho Joong Youn
Journal:  Heart Vessels       Date:  2013-10-31       Impact factor: 2.037

Review 4.  Coronary microvascular dysfunction, microvascular angina, and treatment strategies.

Authors:  Mark A Marinescu; Adrián I Löffler; Michelle Ouellette; Lavone Smith; Christopher M Kramer; Jamieson M Bourque
Journal:  JACC Cardiovasc Imaging       Date:  2015-02

Review 5.  Women with Stable Angina Pectoris and No Obstructive Coronary Artery Disease: Closer to a Diagnosis.

Authors:  Marie Mide Michelsen; Naja Dam Mygind; Daria Frestad; Eva Prescott
Journal:  Eur Cardiol       Date:  2017-08

6.  Human relaxin gene expression delivered by bioreducible dendrimer polymer for post-infarct cardiac remodeling in rats.

Authors:  Young Sook Lee; Joung-Woo Choi; Jung-Eun Oh; Chae-Ok Yun; Sung Wan Kim
Journal:  Biomaterials       Date:  2016-04-26       Impact factor: 12.479

7.  Echocardiographic assessment of coronary artery flow in normal canines and model dogs with myocardial infarction.

Authors:  Nohwon Park; Jaehwan Kim; Miyoung Lee; Soyun Lee; Sunhye Song; Seungjun Lee; Soyoung Kim; Yangwoo Park; Kidong Eom
Journal:  J Vet Sci       Date:  2013-06-30       Impact factor: 1.672

Review 8.  Sex-Specific Aspects in the Pathophysiology and Imaging of Coronary Macro- and Microvascular Disease.

Authors:  Floor Groepenhoff; Sophie H Bots; Elise L Kessler; Ariane A Sickinghe; Anouk L M Eikendal; Tim Leiner; Hester M den Ruijter
Journal:  J Cardiovasc Transl Res       Date:  2019-08-30       Impact factor: 4.132

9.  Coronary microvascular function in patients with isolated systolic and combined systolic/diastolic hypertension.

Authors:  Huseyin Bozbas; Bahar Pirat; Aylin Yildirir; Serpil Eroglu; Vahide Simsek; Elif Sade; Ilyas Atar; Alp Aydinalp; Bulent Ozin; Haldun Muderrisoglu
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-08-27       Impact factor: 3.738

10.  Coronary flow reserve is impaired in patients with obstructive sleep apnea.

Authors:  Serife Savas Bozbas; Serpil Eroglu; Berna Akinci Ozyurek; Fusun Oner Eyuboglu
Journal:  Ann Thorac Med       Date:  2017 Oct-Dec       Impact factor: 2.219

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.